Low GI Diet Impact on Cardiometabolic Risk Factors in Obese Chinese Adults
This study aims to evaluate the impact of a low glycemic index (GI) diet on body mass index (BMI) in obese Chinese adults, by comparing changes in BMI within and between participants.
Low GI diet
Body Weight+6
+ Nutrition Disorders
+ Nutritional and Metabolic Diseases
Treatment Study
Summary
Study start date: March 1, 2021
Actual date on which the first participant was enrolled.Obesity affects nearly 30% of adults in Hong Kong, leading to serious health issues like high blood pressure, heart disease, and type 2 diabetes. One dietary approach that has shown promise in managing weight is the low Glycemic Index (GI) diet. However, most studies on low GI diets have been conducted in Western populations, leaving a gap in understanding its effects on Chinese adults. This study aims to explore the impact and acceptability of a low GI diet compared to a conventional healthy diet on the Body Mass Index (BMI) and other heart-related risk factors in obese Chinese adults living in Hong Kong. The study is designed as a two-arm randomized controlled trial. Participants in the intervention group will receive education on a low GI diet, including a 60-minute face-to-face session with a research nurse and an informational booklet. This will be followed by three 15-minute phone calls at the 2nd, 5th, and 8th weeks. The control group will receive educational pamphlets on obesity and balanced diets, also followed by three 15-minute phone calls at the same intervals. At the start and end of the 12-week period, data on BMI, waist circumference, body fat, blood pressure, blood sugar levels, and other related factors will be collected to measure the effects of the diet.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.166 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Treatment Study
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.Over 18 Years
Range of ages for which participants are eligible to join.Healthy volunteers not allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Criteria
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.2 intervention groups are designated in this study
50% chance of being blinded to the placebo group
Treatment Groups
Group I
PlaceboGroup II
ExperimentalStudy Objectives
Primary Objectives
Secondary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location